Company profile
Endotelix Diagnostics Sàrl
Endotelix is a spin-off from the University of Geneva and dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome including diagnostic tests and treatment options. We are currently developing a new diagnostic test to measure the circulating levels of antiphospholipid antibodies (aPL) as a rapid test (LFA-like). It allows the measuring of anti-ß2GP1 IgG and IgM. This diagnostic test is more sensitive and faster than the current assays. We have also developed an ELISA test for hospital and Research Use Only.
Source: startup.ch
Highlights
Winner Venture Kick
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
